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Summary
 
HLA-G is the only class I determinant of the major histocompatibility complex (MHC) ex-
pressed by the trophoblasts, the fetal cells invading the maternal decidua during pregnancy. A
unique feature of this nonclassical HLA molecule is its low polymorphism, a property that has
been postulated to play an important role in preventing local activation of maternal alloreactive
T and natural killer cells against the fetus. Yet, the mechanisms by which fetal HLA-G can be
recognized as a self-MHC molecule by the maternal immune system remain unclear. Here we
report the novel observation that HLA-G is expressed in the human thymus. Expression is tar-
geted to the cell surface of thymic medullary and subcapsular epithelium. Thymic epithelial cell
lines were generated and shown to express three alternatively spliced HLA-G transcripts, previ-
ously identified in human trophoblasts. Sequencing of HLA-G1 transcripts revealed a few nu-
cleotide changes resulting in amino acid substitutions, all clustered within exon 3 of HLA-G,
encoding for the 
 
a
 
2 domain of the molecule. Our findings raise the possibility that maternal
unresponsiveness to HLA-G–expressing fetal tissues may be shaped in the thymus by a previ-
ously unrecognized central presentation of this MHC molecule on the medullary epithelium.
 
M
 
HC class I molecules are important recognition ele-
ments regulating presentation of self and nonself an-
tigens to cytotoxic CD8
 
1
 
 T cells. MHC class I molecules
have evolved to form two different, though structurally re-
lated, groups of molecules known as class Ia (e.g., classical
HLA-A, -B, and -C) and class Ib (e.g., nonclassical HLA-E,
-F, and -G). Although polymorphism of MHC class Ia an-
tigens plays an important role in establishing the diversity of
immune responses (1), selective pressure has maintained a
limited polymorphism of the class Ib MHC molecules, par-
ticularly at the peptide binding groove (2). Furthermore, in
contrast with the ubiquitous distribution of class Ia mole-
cules, MHC class Ib determinants have a developmentally
regulated or tissue-restricted expression, suggesting im-
mune functions specialized for binding specific antigens
and/or for presentation to particular subpopulations of T
cells.
Among members of the class Ib MHC molecules, hu-
man HLA-G is unique in that its expression is primarily re-
stricted to the cell surface of the extravillous trophoblasts,
the placental tissue of fetal origin invading the maternal de-
cidua during implantation of the embryo (3, 4). Neither
the polymorphic class Ia nor the class II HLA antigens are
expressed by human trophoblasts (5, 6). It has been pro-
posed that the selective expression of nonpolymorphic
HLA-G at this site may protect the semiallogeneic fetal tis-
sues from maternal immune rejection by preventing the ac-
tivation of maternal alloreactive T and NK cells resident in
the decidua (7–11). In fact, a direct role of HLA-G in in-
hibiting NK-mediated lysis of target cells has been demon-
strated (11–13). As for decidual T cells, it is unknown
whether they are restricted by, and therefore tolerant to,
HLA-G. Nevertheless, in the mouse there is evidence that
decidual T cells of the 
 
g
 
/
 
d
 
 lineage are oligoclonal (14) and
restricted by nonpolymorphic MHC class Ib determinants
(15). Interestingly, the same population of 
 
g
 
/
 
d
 
 T cells can
be positively selected in the mouse fetal thymus (16). These
studies suggest that selection events occurring in the thy-
mus may influence the repertoire of T cell immune re-
sponses at the uterine epithelial surface.
An important question is whether maternal effector cells
are controlled exclusively by the peripheral presentation of
nonpolymorphic HLA-G molecules at the uterine–placen-
tal interface or whether central presentation of HLA-G
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molecules occurs in the thymus. Thymic selection events
restricted by HLA-G may provide powerful mechanisms
by which the maternal immune system could efficiently
adapt to accept the fetal graft presenting such HLA deter-
minants. Previous studies have reported very low levels of
HLA-G messenger RNA (mRNA)
 
1
 
 in the fetal thymus
(17, 18), but no evidence has been provided for the expres-
sion of the protein, nor for the identity of the cells exhibit-
ing such expression. In the present study, we therefore in-
vestigated whether HLA-G is expressed in the human
thymus and, specifically, whether its expression localizes to
antigen-presenting elements such as thymic epithelial cells.
 
Materials and Methods
 
Immunohistochemistry and Immunofluorescence Studies.
 
Thymi were
obtained from pediatric donors (1–12 yr old) undergoing elective
surgery for cardiac malformations. Fetal thymi were obtained
from Advanced Bioscience Resources (Alameda, CA). 10 
 
m
 
m cry-
ostat sections of thymic tissues were dried and fixed in either 2%
paraformaldehyde (immunocytochemistry) or absolute ethanol at
 
2
 
20
 
8
 
C (immunofluorescence). Sections were probed with the
anti–HLA-G–specific IB8 mAb (4) followed by a biotin-conju-
gated Fab
 
2
 
 anti–mouse IgM secondary Ab and either streptavidin
alkaline phosphatase or streptavidin Lissamine-Rhodamine. For
immunocytochemistry, sections were counter stained with bril-
liant blue and mounted in Gelmount (Biomeda, Foster City, CA).
For two-color immunofluorescence studies, HLA-G–probed sec-
tions were further blocked with an excess of polyclonal mouse
IgG and incubated in the presence of an FITC-labeled pan-cyto-
keratin mAb (clone KL1; Immunotech, Westbrook, ME) or an
FITC-labeled isotype-matching IgG control. Sections were ana-
lyzed using an Olympus or a Zeiss Axiovert microscope equipped
with a scanning laser confocal attachment (MRC 1024; Bio Rad
Labs., Hercules, CA).
 
Isolation and Phenotypic Characterization of HLA-G
 
1
 
 Thymic Stro-
mal Cells.
 
Thymic fragments were digested with collagenase (10
mg/ml) in the presence of DNase (Boehringer Mannheim, India-
napolis, IN), and thereafter treated with a nonenzymatic dissocia-
tion medium (Sigma Chemical Co., St. Louis, MO). This treat-
ment yields single cells (thymocytes and stromal elements) as well
as some incompletely dissociated cell clusters. This cell prepara-
tion was incubated in ice-cold PBS–2% FCS in the presence of
IB8 mAb followed sequentially by a Fab
 
2
 
 anti–mouse IgM sec-
ondary Ab (Cappel, Durham, NC), streptavidin-Tricolor (CAL-
TAG Labs., Burlingame, CA) and biotin magnetic beads (Miltenyi
Biotec Inc., Sunnyvale, CA). The cell preparation was passed
through 300- and 40-
 
m
 
g nylon meshes to deplete cell aggregates,
and applied to the magnetic column. Column-adherent cells
were then eluted by removing the magnetic field and washing
 
with several column volumes of buffer. Two-color flow cytomet-
ric analysis for HLA-G and epithelial cell adhesion molecule (Ep-
CAM) was performed by staining with IB8 mAb as described
above. After blocking with mouse IgG, cells were incubated with
FITC-labeled anti-EpCAM mAb (clone 323A3; gift of Dr. G.
Chamness, University of Texas, San Antonio, TX) or an FITC-
labeled isotype-matching control IgG. Three-color flow cytometric
analysis for HLA-G, -A, -B, -C, and CD3 was performed by se-
quential labeling with the IB8 mAb followed by an Fab
 
2
 
 anti–
mouse IgM secondary Ab (Cappel) and streptavidin-FITC (CAL-
TAG Labs.), in combination with an RPE-conjugated anti–HLA-A,
-B, and -C mAb (clone G46-2.6; PharMingen, San Diego, CA) and
Cy-Chrome–conjugated anti–human CD3 mAb (clone 145-2C11;
PharMingen). Flow cytometry was performed on a FACScan
 
Ò
 
(Becton Dickinson, San Jose, CA). For cell sorting experiments,
thymic stromal cells were dissociated from the tissue as described
above and let to recover by overnight culture in RPMI–10%
FCS. The next day, cells were harvested and HLA-G
 
high
 
 epithelial
cells purified by sequential enrichment on the magnetic column
followed by fluorescence-activated cell sorting on a FacStar
 
Ò
 
(Becton Dickinson).
 
Generation of Thymic Epithelial Cell Lines.
 
Thymic epithelial cell
lines were generated by collagenase and trypsine digestion of thy-
mic fragments followed by culture in serum-free conditions as
previously described (19). The method yields epithelial cells with
a uniformly bright cobblestone-like appearance by light micros-
copy which are 80–90% pure as determined by cytokeratin stain-
ing. Monolayers of thymic epithelial cells at the third or fourth
passage (
 
z
 
4–6 wk of culture) were grown on glass coverslips,
fixed in cytoskeleton-stabilizing buffer (20) containing 2% parafor-
maldehyde, and permeabilized in PBS–0.1% Triton X-100. After
blocking in PBS–50 mM glycine–5% goat serum, cells were
stained for HLA-G and cytokeratin as described above.
 
Western Blotting.
 
Cell monolayers were lysed in 20 mM Tris/
1% Triton X-100 and protease inhibitors. After removal of insol-
uble material by spinning at 10,000 
 
g
 
 for 30 min, protein concen-
tration was determined by the BCA protein assay (Pierce Chem.
Co., Rockford, IL). 10–20 
 
m
 
g aliquots of total protein were sep-
arated by SDS-PAGE and transferred onto a polyvinylidene fluo-
ride membrane. After blocking, the membrane was probed with
1:100 dilution of the anti–HLA-G mAb 4H84 (culture superna-
tant) or mouse IgG. Antibody binding was detected using a perox-
idase-conjugated secondary antibody and chemoluminescence (Kirke-
gaard & Perry Labs., Inc., Gaithersburg, MD).
 
PCR Amplification of HLA-G Transcripts and Sequencing.
 
Single
strand cDNA was transcribed from 0.5 
 
m
 
g of polyA
 
1
 
 RNA using
avian myeloblastosis virus reverse transcriptase and oligo dT-primers.
One third of this reaction was used as template for PCR amplifica-
tion of HLA-G transcripts expressed in TEC lines. Oligonucleotides
used as primers for reverse transcriptase PCR (RT-PCR) of HLA-G
transcripts were: 5
 
9
 
-AGGATGGTGGTCATGGCG (sense) lo-
cated at the 5
 
9
 
 end of the cDNA and 5
 
9
 
-GGGCTGGTCTCTG-
CACAAAGAGA (antisense) located within the 3
 
9
 
 untranslated
region (21). Cyclophilin-specific primers were: 5
 
9
 
-ATGGTC-
AACCCCACCGTGTTCTTC (sense) and 5
 
9
 
-CATAGATGG-
 
1
 
Abbreviations used in this paper:
 
 EpCAM, epithelial cell adhesion molecule;
FSC, forward side scatter; mRNA, messenger RNA; RT-PCR, reverse
transcriptase PCR.
 
Figure 2.
 
HLA-G expression pattern in the thymic medulla and identification of HLA-G
 
1
 
 epithelial cells. Cryostat sections of human thymus showing
staining for HLA-G protein as revealed by the HLA-G–specific mAb IB8 using an immunofluorescence detection method. (
 
A
 
 and 
 
B
 
) Medullary HLA-G
 
1
 
 cells,
often organized in railway-like structures, are seen to sharply delimit areas of tissue densely packed with thymocytes. (
 
C
 
) Two-color immunofluorescence
analysis of thymic sections stained with a Lissamine-Rhodamine–labeled anti–HLA-G mAb (
 
red fluorescence
 
) and a FITC-labeled pan-cytokeratin mAb
(
 
green fluorescence
 
) demonstrating the colocalization of HLA-G with cytokeratin-positive medullary epithelial cells (
 
yellow
 
). Cells with a dendritic-like mor-
phology positive for HLA-G but negative for cytokeratins are also evident (
 
arrows
 
).
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Figure 1. Expression of HLA-G
by a subset of medullary and subcap-
sular thymic stromal cells. Cryostat
sections of human thymus showing
staining for HLA-G protein as re-
vealed by the HLA-G–specific mAb
IB8 (IgM) using an alkaline phos-
phatase detection method. Expres-
sion of HLA-G is primarily restricted
to the (A) medullary (m), (B) cor-
tico-medullary junction (cmj), and
(C) subcapsular (arrow) regions of the
thymus. Bar (A, B, C, and F) 60 mm.
Within the medulla, HLA-G1 cells
appear as large stromal elements with
big nucleoli (D, inset) often orga-
nized at the periphery of Hassal cor-
puscles (D, bar, 30 mm) or arranged
in “railway”-like strings (E; bar,
12 mm). Background staining ob-
tained using a control IgM antibody
is shown in F.
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ACTTGCCACCAGTGC (antisense). In the studies addressing
the expression of HLA-E, -F, and -G in sorted HLA-G
 
high
 
 cells,
separate PCR reactions were performed using the locus-specific
oligonucleotides and the pan-HLA class I primers listed in Table 1.
The locus specificity of primers used has been previously docu-
mented (22–25). PCR was carried out for 30 cycles of 1 min at
94
 
8
 
C, 1 min at 60
 
8
 
C, and 2 min at 72
 
8
 
C. For semiquantitative
analysis of PCR products, a linear range of amplification was
identified corresponding to cycles 22, 24, 26, and 28 using 1/50
of the total cDNA reaction as template. PCR products were sep-
arated on a 1.8% agarose gel and visualized by ethidium bromide
staining. Densitometric analysis of the bands was performed using
National Institutes of Health Image software (version 1.59b9). For
sequence analysis, bands corresponding to the PCR-amplified
cDNAs were excised from low melting point agarose gels and di-
rectly cloned in a pCR
 
Ô
 
 II vector using a TA cloning system
(Invitrogen, San Diego, CA). Fragments cloned from at least two
separate colonies for each alternatively spliced form of HLA-G
were sequenced from both ends using Sequenase (United States
Biochemical Corp., Cleveland, OH).
 
Results and Discussion
 
Immunohistochemical analysis of human thymic sections
using an HLA-G–specific mAb (clone IB8; reference 4) re-
vealed a distinct pattern of expression restricted to medul-
lary and subcapsular stromal cells (Fig. 1). HLA-G
 
1
 
 cells
were identified within the medulla (Fig. 1 
 
A
 
) and formed a
distinct rim of cells at the corticomedullary junction (Fig. 1 
 
B
 
)
and subcapsular region of the thymus (Fig. 1 
 
C
 
). At higher
magnification, positive cells appeared as large oval shaped
elements often surrounding Hassal corpuscles (Fig. 1 
 
D
 
, in-
set) or organized to form railway-like strings (Fig. 1 
 
E
 
).
These latter structures sharply demarcated areas of the me-
dulla (Fig. 2, 
 
A
 
 and 
 
B
 
) that were densely packed with thy-
mocytes. This distinct pattern of expression was observed
 
in tissue specimens from pediatric donors (e.g., 1–12 yr). In
contrast, fetal thymic tissues (14–22 wk of gestation) re-
vealed only few HLA-G
 
1
 
 cells scattered randomly through-
out the medulla (not shown). Two-color confocal micros-
copy was used to colocalize the expression of HLA-G with
cytokeratin. This analysis revealed that most HLA-G
 
1
 
 cells
are epithelial (Fig. 2 
 
C
 
). Nevertheless, a few HLA-G
 
1
 
 cells
with a dendritic morphology and negative for cytokeratin
were observed in the medulla (Fig. 2 
 
C
 
, 
 
arrows
 
).
To determine whether HLA-G is expressed on the cell
surface, a suspension of thymic stromal cells was prepared
in two steps, a collagenase digestion followed by a nonen-
zymatic dissociation of the thymic tissue. Cells were then
stained with the IB8 mAb and enriched by positive selec-
tion with a magnetic bead–column technique. Flow cyto-
metric analysis of the cells before purification on the col-
umn demonstrated a low percentage (
 
z
 
1%) of HLA-G
 
1
 
cells (Fig. 3 
 
A
 
, 
 
left
 
). However, two discrete populations of
cells expressing intermediate and high levels of HLA-G
(HLA-G
 
int
 
 and HLA-G
 
high
 
, respectively) on the cell surface
could be detected after enrichment on the magnetic col-
umn (Fig. 3 
 
A
 
, 
 
right
 
). HLA-G
 
int
 
 and HLA-G
 
high
 
 cells repre-
sent 33 and 17% of the enriched population, respectively.
To characterize both quantitatively and qualitatively the
thymic epithelial cells expressing HLA-G, the column-
enriched preparation was further stained with an FITC-
labeled antibody specific for EpCAM, a cell-surface epithelial
marker that preferentially labels the medullary epithelium
(26, 27). Fig. 3 
 
B
 
 shows that HLA-G
 
high
 
 cells are strongly
positive for EpCAM. As determined by their forward side
scatter (FSC) values, these cells are relatively large, consis-
tent with the characteristics of most medullary epithelial cells
previously described by immunohistochemical and electron
microscopy studies (28, 29). HLA-G
 
int
 
 cells also comprise
an EpCAM
 
1
 
 population of large to intermediate size cells,
Figure 3. Surface expression of HLA-G on
freshly isolated epithelial cells. A cell suspen-
sion enriched for HLA-G1 cells was obtained
by collagenase digestion and nonenzymatic
dissociation of thymic fragments, followed by
positive selection of IB8-labeled cells using an
immunomagnetic bead separation technique.
(A) Flow cytometric analysis of a single cell
suspension stained for HLA-G before (left) and
after (right) enrichment by positive selection
on the magnetic column. The vertical line
marks the upper limit of the background
intensity of fluorescence obtained using a
control IgM. (B) This HLA-G–enriched cell
population was further probed for the
expression of the surface epithelial marker Ep-
CAM using an anti-EpCAM FITC-labeled
mAb (clone 323A3) or a FITC-labeled iso-
type-matching control IgG, and analyzed by
flow cytometry. The horizontal line marks
the upper limit of the background fluores-
cence obtained with the control IgG (left).
HLA-Ghigh cells (A, R3) comprise cells with a
large FSC and coexpress high levels of
EpCAM, supporting their epithelial nature. HLA-Gint cells (A, R2) comprise EpCAMint-high cells with an intermediate FSC as well as EpCAMlow cells
with a large FSC. HLA-Gneg cells are EpCAMlow-neg.
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as well as a population of large EpCAMlow cells. Thus,
z40% of the cells eluted from the column are EpCAM1
and the majority of these EpCAM1 cells (e.g., z82%) ex-
press HLA-G. These results demonstrate that the HLA-G1
subset comprises cells with the medullary epithelium pheno-
type, as also shown by the in situ immunofluorescence (Fig.
1). Finally, HLA-G2 cells comprise two populations of rela-
tively smaller cells, one EpCAM1 and one EpCAM2.
To assess whether the epithelial cell expression of HLA-G
and classical class Ia HLA antigens are mutually exclusive,
an enriched population of HLA-G1 cells obtained as de-
scribed above was stained by three-color immunofluores-
cence for CD3, HLA-G, and a monomorphic determinant
on classical class Ia antigens. Flow cytometric analysis of
gated CD32 cells demonstrate that z95% of the cells ex-
pressing high to intermediate levels of HLA-G, coexpress
high levels of classical class Ia HLA (mean fluorescence log
intensity 5 1,300 versus control 5 10). The minority pop-
ulation of CD32 HLA-G2 cells comprise cells with low
levels of HLA-A, -B, and -C (mean intensity of fluores-
cence 5 60), a phenotype consistent with the presence of
MHC class Ialow cortical stromal elements within this popu-
lation (30, 31). Only a few cells (z5%) were detected that
were HLA-Ghigh HLA-A, -B, and -C2. Although these data
demonstrate that HLA-G and classical class Ia HLA mole-
cules are coexpressed on thymic epithelium, they raise an
additional question regarding the expression of other non-
classical HLA molecules such as HLA-E and -F. Of these
nonclassical HLA molecules, HLA-E has been reported to
be expressed in the cytotrophoblasts (23). Because specific
antibodies for HLA-E and -F are not available, we deter-
mined the expression of these HLA molecules at the tran-
scriptional level. For this purpose, HLA-Ghigh thymic epi-
thelial cells were purified by fluorescence-activated cell
sorting from pediatric thymi. mRNA from 2–3 3 105
HLA-Ghigh cells was then used as template for PCR ampli-
fication of HLA-E, -F, and -G transcripts using locus-spe-
cific primers (Table 1). PCR reactions were also performed
using a pair of pan-HLA primers for amplification of all
HLA class I mRNAs. The linear range of amplification was
determined for each of the four primers and PCR tran-
scripts, visualized by ethidium bromide staining, were ana-
lyzed by densitometry. The results of this analysis are sum-
marized in Table 1. HLA-E and -F–specific transcripts
were easily detected by PCR, representing 41.5 6 12%
and 31.4 6 10% of the total class I HLA mRNA. Unex-
pectedly, low levels of the full-length HLA-G transcripts
(e.g., 3 6 2.4% of total HLA) were detected in the sorted
HLA-Ghigh cells. Alternatively spliced forms of HLA-G (see
below) were undetectable. It is unlikely that these results
reflected an inefficient amplification of HLA-G mRNA,
since the same set of primers readily amplified HLA-G
mRNAs from fresh thymic tissue and thymic epithelial cell
lines (see below). Rather, these results suggest that HLA-G
mRNAs in sorted cells may be either unstable or truly ex-
pressed at low levels relative to other class I HLA tran-
scripts. This latter possibility implies that the high levels of
expression of the HLA-G protein, demonstrated in situ and
by flow cytometry, may be maintained in thymic epithelial
cells by a highly efficient translation of HLA-G mRNA or
by a low turnover of the cell surface protein.
Alternative splicing of the HLA-G mRNA has been de-
Table 1. Expression of HLA-E, -F, and -G Transcripts in Sorted HLA-Ghigh Thymic Epithelial Cells
Primers Location PCR fragment
Expression
(% of pan-HLA class I)*
bp
HLA-E
59-TCCGAGCAAGAATCAAATGATG Exon 3 700 41.5 6 12
59-GTGTGAGGAAGGGGGTCATG 39-untranslated
HLA-F
59-TATTGGGAGTGGACCACAGGGTAC Exon 2 842 31.4 6 10
59-GGCACAAGTGCAATTCTGCTAC 39-untranslated
HLA-G
59-TTGGGAAGAGGAGACACGGAACAC Exon 2 866 3.3 6 2.4
59-GGGCTGGTCTCTGCACAAAGAGA 39-untranslated
pan-HLA class I
59-TCCCACTCCATGAGGTATTTC Exon 2 777 100
59-CACATGGCAGGTGTATCTCTG Exon 4
Messenger RNA from HLA-Ghigh thymic epithelial cells purified by fluorescence-activated cell sorting, was amplified by PCR using either locus-
specific oligonucleotides or pan-HLA primers corresponding to conserved sequences in all class I genes. Each PCR reaction was performed using
mRNA from 5 3 103 cells. PCR fragments obtained in the linear range of amplification were separated by agarose gel electrophoresis, stained by
ethidium bromide, and analyzed by densitometry. The pixel intensity of each nonclassical HLA transcript is expressed as percentage of that measured
for the total HLA transcript, amplified with pan-HLA primers.
*Data represent mean 6 SEM of three independent cell sorting experiments.
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scribed in human trophoblast and HLA-G–transfected cell
lines (25, 32). The full-length transcript, named HLA-G1,
gives rise to a molecule containing the a1, a2, and a3 do-
mains, forming the basic structure of MHC class I heavy
chain. A shorter HLA-G2 transcript excludes exon 3 en-
coding the a2 domain, thereby creating a protein contain-
ing an a1 domain joined directly to the a3 domain. A
third transcript, HLA-G3, encodes a molecule in which the
a1 domain is directly connected to the transmembrane re-
gion. Most recently, variants of HLA-G1 and -G2 mRNAs
have been reported containing the intron 4 and encoding
for soluble HLA-G proteins (33, 34). To investigate which
of these transcripts are expressed by thymic epithelial cells,
we developed human primary epithelial cell (TEC) lines
from both fetal and pediatric thymi. Expression of HLA-G
proteins in these cell lines can be detected in z10–20% of
cells, though confocal microscopy demonstrates that ex-
pression is primarily at an intracellular location (Fig. 4, B and
C). Western blotting analysis of detergent extracts from
TECs using an HLA-G–specific mAb (clone 4H84; McMas-
ter, M.T., and S.J. Fisher, manuscript in preparation) dem-
onstrates that the predominant HLA-G protein expressed
has an apparent molecular weight of 38–40 kD (Fig. 4 D).
Amplification of HLA-G–specific sequences from mRNA
of TEC lines by RT-PCR demonstrated 1,200-, 900-, and
500-bp DNA fragments (Fig. 5 A) consistent with mRNA
transcripts for the membrane-bound HLA-G1, -G2, and -G3
alternatively spliced isoforms, respectively (25, 32). Ampli-
fication of these transcripts was consistently obtained in six
independent TEC lines. Semiquantitative analysis of these
PCR products obtained in the linear range of amplification
from mRNA of three TEC lines revealed that the HLA-
G2 and -G3 transcripts represent 20.5 6 3.9% and 4.4 6
3.5% (mean 6 SEM) of the HLA-G1 mRNA, respectively.
PCR amplification of HLA-G transcripts from mRNA of
fresh thymic tissue obtained from three separate donors re-
vealed a similar pattern of frequency of the HLA-G2 and
-G3 transcripts relative to the HLA-G1 transcript (e.g.,
29.8 6 4.1% and 0.57 6 0.2%, respectively). Sequence
analysis of HLA-G1 and -G2 cDNAs isolated from two pe-
diatric thymic epithelial cell lines confirmed an intact pri-
mary structure and correct splicing of the corresponding
transcripts. In particular, HLA-G1 cDNAs revealed a nucle-
otide sequence consistent with the splicing of exons 1, 2, 3,
4, 5, 6, and 8 of the HLA-G gene (21; Fig. 5 B). In con-
trast, HLA-G2 cDNAs revealed a sequence consistent with
the splicing of exons 1, 2, 4, 5, 6, and 8. Similar analysis of
HLA-G1 and -G2 cDNAs obtained from a fetal thymic epi-
thelial cell line revealed an intact primary structure of the
HLA-G1 transcript, but an HLA-G2 mRNA containing a
33-nucleotide deletion within exon 4. Fig. 5 B shows the lo-
cation of the sequence variations identified by our analysis,
as compared to the cDNA sequence of the full-length
HLA-G reported by Shukla et al. (35). Notably, within the
Figure 4. Expression of HLA-G
in cultured human thymic epi-
thelial cell lines. Confocal micros-
copy of primary thymic epithelial
cells stained with an FITC-con-
jugated pan-cytokeratin mAb (A)
and a Lissamine-Rhodamine–
conjugated IB8 mAb (B), or
4H84 mAb (C). Analysis of sin-
gle confocal planes from a z se-
ries revealed that HLA-G–spe-
cific staining is predominantly
intracytoplasmic. Bars: (B) 45 mm;
and (C) 22 mm. (D) Western
blotting analysis of detergent ly-
sates from a human TEC line
(lanes 1 and 6), Jurkat lymphoma
cells (HLA-A, -B, -C1, and -G2;
lanes 2 and 4) and JEG-3 chorio-
carcinoma cells (HLA-A, -B2,
and HLA-G1; lanes 3 and 5).
The membrane was probed
with an anti–HLA-G IgG mAb
specific for a peptidic sequence
within the a1 domain of HLA-G
(clone 4H84; McMaster, M.T.,
and S.J. Fisher, manuscript in prep-
aration; lanes 1–3) or mouse IgG
(lanes 4–6). Antibody binding
was detected by chemilumines-
cence. 20 mg total proteins were
loaded in lanes 1 and 6; 10 mg of
total proteins were loaded in the
remaining lanes. A prominent
band of z38–40 kD is detected
in TEC and JEG-3 extracts, but
not in Jurkat’s extracts (arrow). 
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HLA-G1 transcripts, most nucleotide variations resulting in
amino acid changes are clustered within exon 3, encoding for
the a2 domain, located between the b-pleated sheet and
the start of the a2 helix. Interestingly, such amino acid
changes fall into the same stretch of sequence (e.g., amino
acids 101–138) previously identified as a mutational hot spot
by genomic sequence analysis of HLA-G alleles (36). The
data indicate that, unlike classical HLA class I molecules in
which polymorphic residues restricting peptide binding are
present in both the a1 and a2 domains, polymorphism of
HLA-G appears to be largely restricted to the a2 domain.
The deletion which we report within HLA-G2 cDNA ex-
pressed by the fetal cell line includes the loss of cysteine
residue 259 located in the a3 domain. It is conceivable that
this sequence change results in a gross alteration of protein
structure, suggesting that this transcript may either yield a
protein with an altered function or behave as a pseudogene.
The present data demonstrate the compartment-specific
expression of HLA-G molecules in the human thymus by
medullary epithelial cells. These results raise the possibility
that the T cell immune response of the mother to the fetus
may be regulated by interactions of developing T cell pro-
genitors with thymic HLA-G. The development of T cells
restricted by this relatively nonpolymorphic MHC mole-
cule during thymic ontogeny and its selective expression in
the placenta during pregnancy, may both be required to
ensure successful conception despite fetal–maternal dispari-
ties at polymorphic HLA loci. Thus, it is possible that cases
of recurrent fetal miscarriage of immune etiology may be
related to altered expression of HLA-G in the thymus.
The evidence that expression of MHC transgenes on med-
ullary thymic epithelial cells result in antigen-specific T cell
tolerance by anergy or unresponsiveness (37–39) rather
than clonal deletion, suggests at least two mechanisms by
which HLA-G expressed at this particular location in the
thymus may influence maternal immune responses to fetal
tissues presenting HLA-G. Mechanisms of tolerance by im-
mune unresponsiveness may indeed be operative at the ma-
ternal–fetal interface since decidual cells are poor respond-
ers to mitogens and allogenic stimuli (9). An alternative
mechanism by which thymic HLA-G may influence pe-
ripheral immune responses can be inferred by its expression
in the thymic medulla, a location open to the recirculation
of peripheral lymphoid cells (40). Thus, HLA-G may be
involved in the uptake or presentation of circulating anti-
gens (e.g., shed by the fetal cells of the placenta) to mature
Figure 5. PCR amplification and sequence of HLA-G transcripts expressed by thymic epithelial cell lines. (A) Agarose gel electrophoresis of HLA-G
alternatively spliced transcripts amplified by RT-PCR from mRNA obtained from a primary human thymic epithelial cell line. 1,200-, 900- and 500-bp
bands are detected (lane 1), consistent with the presence of the three main alternatively spliced forms of HLA-G, namely HLA-G1, -G2, and -G3 described
by Ishitani et al. (32). In contrast, mRNA from freshly isolated thymocytes (lane 2) demonstrates no HLA-G–specific transcripts. A positive control PCR
reaction for thymocyte mRNA showing a 237-bp DNA fragment of cyclophillin is displayed in lane 3. A negative control PCR reaction run using HLA-
G–specific primers and no cDNA template is shown in lane 4. Molecular weight markers corresponding to a 100-bp DNA ladder (GIBCO BRL, Gaith-
ersburg, MD) are shown in the left lane (MW). (B) Primary structure and sequence variations identified within the HLA-G1 and -G2 cDNAs amplified
by PCR from two of the three TEC lines that were sequenced, e.g., FT6 and HTS 2.900. Sequence variations are displayed with respect to their location
within each exon and aligned with the published sequence of a full-length HLA-G cDNA expressed by placental trophoblasts reported by Shukla et al.
(35). SP, signal peptide; TM, transmembrane domain. Stretches of nucleotide sequences are identified by base pair numbers for orientation. Dashes rep-
resent sequence identity; stars represent gaps. Codons containing point mutations are boxed. Mutations resulting in amino acid variations are also shad-
owed. Note the prevalence of point mutations resulting in amino acid changes within exon 4. The CTC fi ATC (leufi ile) substitution corresponding to
amino acid position 110 of the HTS 2.900 line has been previously reported (35). Though the GGC fi GAC (glyfi asp) substitution at amino acid posi-
tion 120 of the FT6 line has not been reported, a variety of other amino acid substitutions have been identified at the very same position (36).
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peripheral T cells recirculating to this compartment. In sup-
port of this possibility, there is evidence that murine med-
ullary, but not cortical, TECs can present soluble antigens
(41), and that MHC class I–dependent pathways of presen-
tation exist for exogenous antigens (42, 43).
Proposing a role for HLA-G in thymic-dependent T cell
development depends upon the demonstration that HLA-G
is expressed at the cell surface of thymic antigen-presenting
cells. In this regard, our data represent the first evidence that
this is the case. The antigen-presenting function of HLA-G
is supported by the conservation of an MHC class I–like
structure, at least for the HLA-G1 isoform (7), its ability to
bind CD8 (44), and the presence of endogenous peptides
bound in the groove (45). Interestingly, our data, as well as
reports by others (36, 46), indicate that most sequence vari-
ability is clustered within the a2 domain of the molecule.
This suggests that the a1, rather than a2, domain may im-
pose greater structural constraints for binding of relatively
invariant peptidic motifs to HLA-G. If indeed few peptide
variants are presented by this MHC class I molecule as pre-
dicted by its low polymorphism, the predominant expres-
sion of HLA-G on a subset of medullary epithelial cells im-
plies that a qualitative difference may exist in the repertoire
of peptides presented by medullary and cortical TECs in
the human thymus. Interestingly, the expression of a non-
polymorphic MHC class II molecule has been described on
a subset of medullary TECs in the mouse thymus (47–49).
It is possible that the medulla is specialized for the presenta-
tion of specific antigenic peptides in the context of non-
polymorphic MHC molecules.
We propose that in contrast with the universal expres-
sion of classical polymorphic MHC molecules, the targeted
expression of the olygomorphic HLA-G to the maternal
thymus and the fetal trophoblasts may have been selected
and conserved for the immunological protection of preg-
nancy. Compartimentalization of the oligomorphic HLA-G
to the thymic medulla would not interfere with selection
events on polymorphic MHC molecules expressed in the
cortex, the latter being required to impart a broad spectrum
of immune responses to environmental antigens.
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